Green Nanotechnology of Yucca filamentosa-Phytochemicals-Functionalized Gold Nanoparticles-Antitumor Efficacy Against Prostate and Breast Cancers

被引:9
作者
Thipe, Velaphi C. [1 ,2 ]
Jatar, Ananya [1 ]
Karikachery, Alice Raphael [1 ,2 ]
Katti, Kavita K. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Missouri, Inst Green Nanotechnol, Columbia, MO 65212 USA
[2] Univ Missouri, Dept Radiol, Columbia, MO 65212 USA
[3] Univ Missouri, Dept Phys, Columbia, MO 65211 USA
[4] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA
[5] Univ Missouri, Canc Nanotechnol, Columbia, MO 65211 USA
关键词
Y; filamentosa; phytoconstituents; gold nanoparticles; anticancer; IN-VITRO; PHOTOTHERMAL THERAPY; NATURAL-PRODUCTS; TIMOSAPONIN BII; TUMOR; TOXICITY; MEDICINE; AGENT;
D O I
10.2147/NSA.S437812
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Purpose: We report an innovative green nanotechnology utilizing an electron-rich cocktail of phytochemicals from Yucca filamentosa L. to synthesize biocompatible gold nanoparticles without the use of any external chemical reducing agents and evaluate their antiMethods: Yucca filamentosa L. extract, containing a cocktail of phytochemicals, was prepared, and used to transform gold salt into Y. filamentosa phytochemicals encapsulated gold nanoparticles (YF-AuNPs). Additionally, gum arabic stabilized YF-AuNPs (GAYFAuNPs) were also prepared to enhance the in vitro/in vivo stability. Anticancer activity was evaluated against prostate (PC-3) and breast (MDAMB-231) cancer cell lines. Targeting abilities of gold nanoparticles were tested using pro-tumor macrophage cell lines. Results: Comprehensive characterization of new nanomedicine agents YF-AuNPs and GAYF-AuNPs revealed spherical, and monodisperse AuNPs with moderate zeta potentials (-19 and -20 mV, respectively), indicating in vitro/in vivo stability. The core size of YF-AuNPs (14 +/- 5 nm) and GAYF-AuNPs (10 +/- 5 nm) is suitable for optimal penetration into tumor cells through both enhanced permeability and retention (EPR) effect as well as through the receptor mediated endocytosis. Notably, YF-AuNPs exhibited potent anticancer activity against prostate (PC-3) and breast tumors (MDAMB-231) by inducing early and late apoptotic stages. Moreover, YF-AuNPs resulted in elevated levels of anti-tumor cytokines (TNF-alpha and IL-12) and reduced levels of pro-tumor cytokines (IL-6 and IL-10), provide compelling evidence on the immunomodulatory property of YF-AuNPs. Conclusion: Overall, these Y. filamentosa phytochemicals functionalized nano-Ayurvedic medicine agents demonstrated selective toxicity to cancer cells while sparing normal cells. Most notably, to our knowledge, this is the first study that shows YF-AuNP's targeting efficacy toward pro-tumor macrophage cell lines, suggesting an immunomodulatory pathway for cancer treatment. This work introduces a novel avenue for herbal and nano-Ayurvedic approaches to human cancer treatment, mediated through selective efficacy and immunomodulatory potential.
引用
收藏
页码:19 / 40
页数:22
相关论文
共 70 条
[1]   Potential influence of Yucca extract as feed additive on greenhouse gases emission for a cleaner livestock and aquaculture farming - A review [J].
Adegbeye, Moyosore Joseph ;
Elghandour, Mona M. M. Y. ;
Cedillo Monroy, Jose ;
Abegunde, Taye Olurotimi ;
Salem, Abdelfattah Z. M. ;
Barbabosa-Pliego, Alberto ;
Faniyi, Tolulope O. .
JOURNAL OF CLEANER PRODUCTION, 2019, 239
[2]   Mangiferin functionalized radioactive gold nanoparticles (MGF-198AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy [J].
Al-Yasiri, A. Y. ;
Khoobchandani, M. ;
Cutler, C. S. ;
Watkinson, L. ;
Carmack, T. ;
Smith, C. J. ;
Kuchuk, M. ;
Loyalka, S. K. ;
Lugao, A. B. ;
Katti, K. V. .
DALTON TRANSACTIONS, 2017, 46 (42) :14561-14571
[3]   Facile biofabrication of silver nanoparticles using Salvia officinalis leaf extract and its catalytic activity towards Congo red dye degradation [J].
Albeladi, Shroog Shdied Royji ;
Malik, Maqsood Ahmad ;
Al-thabaiti, Shaeel Ahmed .
JOURNAL OF MATERIALS RESEARCH AND TECHNOLOGY-JMR&T, 2020, 9 (05) :10031-10044
[4]   Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer [J].
Axiak-Bechtel, Andra M. ;
Upendran, Anandhi ;
Lattimer, Jimmy C. ;
Kelsey, James ;
Cutler, Cathy S. ;
Selting, Kim A. ;
Bryan, Jeffrey N. ;
Henry, Carolyn J. ;
Boote, Evan ;
Tate, Deborah J. ;
Bryan, Margaret E. ;
Katti, Kattesh V. ;
Kannan, Raghuraman .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :5001-5011
[5]   Tumor microenvironment complexity and therapeutic implications at a glance [J].
Baghba, Roghayyeh ;
Roshangar, Leila ;
Jahanban-Esfahlan, Rana ;
Seidi, Khaled ;
Ebrahimi-Kalan, Abbas ;
Jaymand, Mehdi ;
Kolahian, Saeed ;
Javaheri, Tahereh ;
Zare, Peyman .
CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
[6]   Role of myeloid cells in the tumor microenvironment [J].
Balakrishnan, Arpita ;
Vig, Mohini ;
Dubey, Shweta .
JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
[7]   Macrophage Polarization States in the Tumor Microenvironment [J].
Boutilier, Ava J. ;
Elsawa, Sherine F. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
[8]   The Role of Macrophages in Cancer Development and Therapy [J].
Cendrowicz, Ewa ;
Sas, Zuzanna ;
Bremer, Edwin ;
Rygiel, Tomasz P. .
CANCERS, 2021, 13 (08)
[9]   Green synthesis of silver nanoparticles using aqueous extracts of three Sideritis species from Turkey and evaluations bioactivity potentials [J].
Ceylan, Ramazan ;
Demirbas, Ayse ;
Ocsoy, Ismail ;
Aktumsek, Abdurrahman .
SUSTAINABLE CHEMISTRY AND PHARMACY, 2021, 21
[10]   Gold Nanoparticle Based X-Ray Contrast Agent for Tumor Imaging in Mice and Dog: A Potential Nano-Platform for Computer Tomography Theranostics [J].
Chanda, Nripen ;
Upendran, Anandhi ;
Boote, Evan J. ;
Zambre, Ajit ;
Axiak, Sandra ;
Selting, Kimberly ;
Katti, Kattesh V. ;
Leevy, W. Matthew ;
Afrasiabi, Zahra ;
Vimal, Jatin ;
Singh, Jason ;
Lattimer, Jimmy C. ;
Kannan, Raghuraman .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (03) :383-392